The safety and efficacy of minimally invasive discectomy: a meta-analysis of prospective randomised controlled trials

被引:31
|
作者
Chang, Xian [1 ]
Chen, Bin [1 ]
Li, Hai-yin [1 ]
Han, Xiao-bo [1 ]
Zhou, Yue [1 ]
Li, Chang-qing [1 ]
机构
[1] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing 400037, Peoples R China
关键词
Meta-analysis; Minimally invasive discectomy; Standard discectomy; Lumbar disc herniation; Randomised controlled trial; Surgical procedures; LUMBAR DISC HERNIATION; CONVENTIONAL MICRODISKECTOMY; MICROENDOSCOPIC DISKECTOMY; SYSTEMATIC REVIEWS; TUBULAR DISKECTOMY; BACK-PAIN; SURGERY; MICRODISCECTOMY; MANAGEMENT; SCIATICA;
D O I
10.1007/s00264-014-2331-0
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Purpose The objective of this study was to compare the safety and efficacy of minimally invasive discectomy (MID) with standard discectomy (SD) and determine whether the use of the MID technique could decrease the recurrence of lumbar disc herniation (LDH) after the surgery. Methods In February 2014, a comprehensive search was performed in PubMed, EMBASE, Web of Science, Cochrane Library and the Chinese Biological Medicine Database. Only randomised controlled trials (RCT) that compared MID with SD for the surgical management of LDH were included. These trials were carefully picked out following the inclusion and exclusion criteria. Using the Cochrane Collaboration guidelines, two authors independently extracted data and assessed these trials' quality. The age of the patients, size of incision, surgical time, blood loss, visual analogue scale (VAS) score after the surgery, hospital stay, disc herniation recurrence, X-ray exposure and surgical costs in these studies were abstracted and synthesised by a meta-analysis with RevMan 5.2.0 software, and the main results (VAS score after the surgery and disc herniation recurrence) of publication bias were examined by Stata 12.0. Results Overall, 16 trials involving 2,139 patients meeting our criteria were included and analysed. Comparing MID and SD, the former was more likely to increase disc herniation recurrence [relative risk (RR) = 1.95, 95 % confidence interval (CI) 1.19-3.19, p = 0.008], and it involved a smaller size of incision [mean difference (MD) = -1.91, 95 % CI -3.33 to -0.50, p = 0.008], shorter hospital stay, longer operating time (MD = 11.03, 95 %C I 6.62-15.44, p < 0.00001) and less blood loss (MD = -13.56, 95 % CI -22.26 to -4.87, p = 0.002), while no statistical difference appeared with regard to the age of the patients, VAS score after the surgery, X-ray exposure, hospital stay and surgical costs. Conclusions Based on available evidence, MID results in less suffering for patients during the hospital course with a similar clinical efficacy compared to SD. This makes MID a promising procedure for patients with LDH; however, to popularise it greater effort is required to reduce disc herniation recurrence.
引用
收藏
页码:1225 / 1234
页数:10
相关论文
共 50 条
  • [41] Efficacy and safety of preoperative chewing gum for undergoing elective surgery: A meta-analysis of randomised controlled trials
    Zhou, Tingting
    Yang, Li
    [J]. JOURNAL OF CLINICAL NURSING, 2023, 32 (23-24) : 8149 - 8150
  • [42] Efficacy and safety of tranexamic acid in acute upper gastrointestinal bleeding: meta-analysis of randomised controlled trials
    Kamal, Faisal
    Khan, Muhammad Ali
    Lee-Smith, Wade
    Sharma, Sachit
    Imam, Zaid
    Jowhar, Dawit
    Petryna, Ellen
    Marella, Hemnishil K.
    Aksionav, Pavel
    Iqbal, Umair
    Tombazzi, Claudio
    Howden, Colin W.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (12) : 1390 - 1397
  • [43] Cardiovascular Safety of Lumiracoxib: A Meta-Analysis of Randomised Controlled Trials in Patients with Osteoarthritis
    Mackenzie, Isla S.
    Wei, Li
    MacDonald, Thomas M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S354 - S354
  • [44] Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis
    Isla S. Mackenzie
    Li Wei
    Thomas M. MacDonald
    [J]. European Journal of Clinical Pharmacology, 2013, 69 : 133 - 141
  • [45] Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis
    Mackenzie, Isla S.
    Wei, Li
    MacDonald, Thomas M.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (02) : 133 - 141
  • [46] Efficacy and Safety of Cilostazol for Atherosclerosis: A Meta-analysis of Randomized Controlled Trials
    Wan, Hongbing
    Huang, Tieqiu
    Yang, Pingping
    Wu, Tao
    Zhang, Hongzhou
    Wu, Qinghua
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (03) : 390 - +
  • [47] SAFETY OF GLUCOCORTICOIDS FOR EARLY RHEUMATOID ARTHRITIS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
    Mitrovic, S.
    Fardet, L.
    Vatier, C.
    Barnetche, T.
    Schaeverbeke, T.
    Gaujoux-Viala, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 228 - 228
  • [48] Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
    Liu, Hongyan
    Wang, Guoqi
    Wu, Ting
    Mu, Yiming
    Gu, Weijun
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [49] Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials
    Avouac, J.
    Gossec, L.
    Dougados, M.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2007, 15 (08) : 957 - 965
  • [50] Efficacy and safety of romosozumab: a meta-analysis of placebo-controlled trials
    Kobayashi, Takaomi
    Hara, Megumi
    Shimanoe, Chisato
    Morimoto, Tadatsugu
    Masaaki, Mawatari
    Ito, Koji
    Shimazaki, Takafumi
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2024,